
Waters Corporation WAT
$ 383.92
-2.11%
Quarterly report 2025-Q3
added 11-04-2025
Waters Corporation EBITDA per Share 2011-2025 | WAT
Annual EBITDA per Share Waters Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.39 | 5.9 | 15.8 | 14.5 | 11.5 | 10.6 | 9.7 | 8.52 | 7.89 | 7.06 | 6.27 | 6.17 | 6.06 | 5.93 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.8 | 5.9 | 8.73 |
Quarterly EBITDA per Share Waters Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.73 | 3.65 | 2.92 | - | 4.03 | 3.61 | 2.63 | - | 3.48 | 3.7 | 3.28 | - | 4.12 | - | 3.51 | 4.32 | 3.99 | 3.18 | 3.01 | 4.24 | 3.35 | 3.04 | 1.35 | 3.71 | 3.25 | 2.99 | 1.86 | 3.27 | 2.83 | 2.7 | 2.03 | 2.9 | 2.57 | 2.31 | 1.64 | 2.59 | 2.36 | 2.2 | 1.54 | 2.22 | 2.06 | 1.85 | 1.58 | 2.07 | 2.07 | 1.61 | 1.15 | 2.07 | 1.72 | 1.53 | 1.37 | 1.84 | 1.7 | 1.55 | 1.33 | 1.85 | 1.7 | 1.51 | 1.36 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.32 | 1.15 | 2.55 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.36 | -4.05 % | $ 176 M | ||
|
Brainsway Ltd.
BWAY
|
-0.16 | $ 17.05 | -2.15 % | $ 99.4 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-70.8 | $ 1.63 | -2.11 % | $ 2.07 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
18.3 | $ 221.54 | -1.96 % | $ 40.2 B | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 38.85 | 2.32 % | $ 1.08 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Danaher Corporation
DHR
|
7.64 | $ 227.08 | -2.28 % | $ 166 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
-1.96 | $ 11.92 | -6.58 % | $ 338 M | ||
|
DexCom
DXCM
|
2.03 | $ 66.91 | -2.94 % | $ 25.8 B | ||
|
CareDx, Inc
CDNA
|
-3.51 | $ 20.44 | 3.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
-2.87 | $ 105.26 | 4.46 % | $ 4.15 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-434 | $ 3.59 | -25.21 % | $ 115 K | ||
|
Exact Sciences Corporation
EXAS
|
-4.08 | $ 101.58 | 0.21 % | $ 18.8 B | ||
|
Co-Diagnostics
CODX
|
-1.41 | $ 0.34 | -2.96 % | $ 9.98 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 27.13 | 0.26 % | $ 820 M | ||
|
Guardant Health
GH
|
-3.27 | $ 102.09 | 0.7 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 26.6 | -1.52 % | $ 20 B | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-3.01 | $ 134.29 | -1.58 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
11.5 | $ 192.57 | -0.96 % | $ 9.89 B | ||
|
Quidel Corporation
QDEL
|
3.59 | $ 28.79 | -2.93 % | $ 1.21 B | ||
|
Quotient Limited
QTNT
|
-0.806 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
16.6 | $ 182.21 | 0.35 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
-0.22 | $ 7.94 | -1.0 % | $ 1.03 B | ||
|
Laboratory Corporation of America Holdings
LH
|
20.6 | $ 263.51 | -0.46 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 186.28 | -1.92 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
15.3 | $ 701.07 | -0.91 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
7.54 | $ 66.11 | 4.76 % | $ 4.57 B | ||
|
Agilent Technologies
A
|
5.49 | $ 139.44 | -2.4 % | $ 42.4 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.55 | -1.07 % | $ 5.86 M | ||
|
Bioventus
BVS
|
-0.39 | $ 7.59 | 2.29 % | $ 475 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
2.37 | $ 1 395.23 | -1.85 % | $ 29.6 B | ||
|
Myriad Genetics
MYGN
|
-0.69 | $ 7.26 | -0.62 % | $ 658 M | ||
|
ENDRA Life Sciences
NDRA
|
-20.1 | $ 5.47 | -7.6 % | $ 2.94 M |